0001214659-21-001943.txt : 20210216
0001214659-21-001943.hdr.sgml : 20210216
20210216160129
ACCESSION NUMBER: 0001214659-21-001943
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20201231
FILED AS OF DATE: 20210216
DATE AS OF CHANGE: 20210216
EFFECTIVENESS DATE: 20210216
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Octagon Capital Advisors LP
CENTRAL INDEX KEY: 0001839435
IRS NUMBER: 843576791
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-20958
FILM NUMBER: 21637793
BUSINESS ADDRESS:
STREET 1: 654 MADISON AVENUE
STREET 2: 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10065
BUSINESS PHONE: 212-369-2829
MAIL ADDRESS:
STREET 1: 654 MADISON AVENUE
STREET 2: 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10065
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001839435
XXXXXXXX
12-31-2020
12-31-2020
false
Octagon Capital Advisors LP
654 MADISON AVENUE
16TH FLOOR
NEW YORK
NY
10065
13F HOLDINGS REPORT
028-20958
N
Justin Hirsch
Chief Compliance Officer and Chief Financial Officer
212-369-2829
/s/ Justin Hirsch
New York
NY
02-16-2021
0
31
288474
INFORMATION TABLE
2
infotable.xml
4D MOLECULAR THERAPEUTICS IN
COM
35104E100
15659
377777
SH
SOLE
377777
0
0
ACCELERON PHARMA INC
COM
00434H108
14376
112363
SH
SOLE
112363
0
0
ACLARIS THERAPEUTICS INC
COM
00461U105
2265
350000
SH
SOLE
350000
0
0
APELLIS PHARMACEUTICALS INC
COM
03753U106
31367
548374
SH
SOLE
548374
0
0
ARCUS BIOSCIENCES INC
COM
03969F109
7788
300000
SH
SOLE
300000
0
0
ARCUTIS BIOTHERAPEUTICS INC
COM
03969K108
2813
100000
SH
SOLE
100000
0
0
ARVINAS INC
COM
04335A105
15160
178500
SH
SOLE
178500
0
0
AVIDITY BIOSCIENCES INC
COM
05370A108
10975
430041
SH
SOLE
430041
0
0
AXSOME THERAPEUTICS INC
COM
05464T104
1629
20000
SH
SOLE
20000
0
0
CALLIDITAS THERAPEUTICS AB
SPONSERED ADS
13124Q106
6724
200000
SH
SOLE
200000
0
0
CARDIFF ONCOLOGY INC
COM
14147L108
11694
650000
SH
SOLE
650000
0
0
CELLDEX THERAPEUTICS INC NEW
COM NEW
15117B202
18245
1041398
SH
SOLE
1041398
0
0
CHEMOCENTRYX INC
COM
16383L106
13937
225076
SH
SOLE
225076
0
0
CURIS INC
COM NEW
231269200
18018
2200000
SH
SOLE
2200000
0
0
DYNE THERAPEUTICS INC
COM
26818M108
10112
481538
SH
SOLE
481538
0
0
FIBROGEN INC
COM
31572Q808
5416
146014
SH
SOLE
146014
0
0
GOSSAMER BIO INC
COM
38341P102
15116
1563138
SH
SOLE
1563138
0
0
HELIX ACQUISITION CORP
COM CL A
G4444C102
4548
400000
SH
SOLE
400000
0
0
I MAB
SPONSORED ADS
44975P103
21432
454550
SH
SOLE
454550
0
0
INVENTIVA SA
ADS
46124U107
2900
200000
SH
SOLE
200000
0
0
IVERIC BIO INC
COM
46583P102
4699
680036
SH
SOLE
680036
0
0
JIYA ACQUISITION CORP
COM CL A
47760M102
3090
300000
SH
SOLE
300000
0
0
KADMON HLDGS INC
COM
48283N106
1802
434114
SH
SOLE
434114
0
0
KINIKSA PHARMACEUTICALS LTD
COM CL A
G5269C101
5217
295238
SH
SOLE
295238
0
0
KRONOS BIO INC
COM
50107A104
4366
146173
SH
SOLE
146173
0
0
KURA ONCOLOGY INC
COM
50127T109
4899
150000
SH
SOLE
150000
0
0
NGM BIOPHARMACEUTICALS INC
COM
62921N105
2279
75227
SH
SOLE
75227
0
0
PMV PHARMACEUTICALS INC
COM
69353Y103
15378
250000
SH
SOLE
250000
0
0
REVOLUTION MEDICINES INC
COM
76155X100
4994
126136
SH
SOLE
126136
0
0
TAYSHA GENE THERAPIES INC
COM SHS
877619106
8504
320440
SH
SOLE
320440
0
0
VIELA BIO INC
COM
926613100
3072
85409
SH
SOLE
85409
0
0